Prognostic Values of Proliferating Cell Nuclear Antigen (PCNA) and Ki-67 for Radiotherapy of Oesophageal Squamous Cell Carcinomas

Overview

Journal Br J Cancer

Specialty Oncology

Date 1999 Jul 17

PMID 10408843

Citations 3

Authors

Y Okuno

Y Nishimura

I Kashu

K Ono

M Hiraoka

Affiliations

Soon will be listed here.

Abstract

The relationship of immunohistochemical indices of proliferating cell nuclear antigen (PCNA) and Ki-67 to local control and survival rates for patients with oesophageal squamous cell carcinomas treated by definitive radiotherapy (RT) was investigated. Biopsy materials before RT were obtained from 65 patients with oesophageal cancer. The median PCNA labelling index (LI) and the median Ki-67 LI were 52% and 45% respectively. The PCNA LI was independent of known prognostic factors on local control for oesophageal cancer, although Ki-67 LI correlated with several prognostic factors. In the univariate analysis, patients with the PCNA LI of < 52% or the Ki-67 LI of < 45% showed significantly higher local recurrence rates than those with higher LIs (both P < 0.05). This difference in local control rate according to LIs was prominent for the patients treated with conventional fractionation. In the multivariate analysis, T-stage (P = 0.0056) and PCNA LI (P = 0.0332) were significant factors for local control in the final model using a stepwise regression procedure. In conclusion, PCNA LI and Ki-67 LI were significantly correlated with local control probabilities in oesophageal squamous cell carcinomas treated by definitive RT.

Citing Articles

A multi-omics study delineates new molecular features and therapeutic targets for esophageal squamous cell carcinoma.

Jin X, Liu L, Wu J, Jin X, Yu G, Jia L Clin Transl Med. 2021; 11(9):e538.

PMID: 34586744 PMC: 8473482. DOI: 10.1002/ctm2.538.

Influence of XRCC4 expression in esophageal cancer cells on the response to radiotherapy.

Hori M, Someya M, Matsumoto Y, Nakata K, Kitagawa M, Hasegawa T Med Mol Morphol. 2016; 50(1):25-33.

PMID: 27338590 DOI: 10.1007/s00795-016-0144-5.

Analysis and results of Ku and XRCC4 expression in hypopharyngeal cancer tissues treated with chemoradiotherapy.

Hayashi J, Sakata K, Someya M, Matsumoto Y, Satoh M, Nakata K Oncol Lett. 2012; 4(1):151-155.

PMID: 22807979 PMC: 3398378. DOI: 10.3892/ol.2012.674.

References

Bravo R . Existence of two populations of cyclin/proliferating cell nuclear antigen during the cell cycle: association with DNA replication sites. J Cell Biol. 1987; 105(4):1549-54. PMC: 2114668. DOI: 10.1083/jcb.105.4.1549. View

Tsurusawa M, Fujimoto T . Cell cycle progression and phenotypic modification of Ki67 antigen-negative G1- and G2-phase cells in phorbol ester-treated Molt-4 human leukemia cells. Cytometry. 1995; 20(2):146-53. DOI: 10.1002/cyto.990200207. View

Withers H, Taylor J, Maciejewski B . The hazard of accelerated tumor clonogen repopulation during radiotherapy. Acta Oncol. 1988; 27(2):131-46. DOI: 10.3109/02841868809090333. View

Mendonca M, Rodriguez A, Alpen E . Quiescence in 9L cells and correlation with radiosensitivity and PLD repair. Radiat Res. 1989; 117(3):433-47. View

Yu C, Dublin E, Camplejohn R, Levison D . Optimization of immunohistochemical staining of proliferating cells in paraffin sections of breast carcinoma using antibodies to proliferating cell nuclear antigen and the Ki-67 antigen. Anal Cell Pathol. 1995; 9(1):45-52. View

Tinnemans M, Lenders M, ten Velde G, Wagenaar S, Blijham G, Ramaekers F . Evaluation of proliferation parameters in in vivo bromodeoxyuridine labelled lung cancers. Virchows Arch. 1995; 427(3):295-301. DOI: 10.1007/BF00203398. View

Youssef E, Matsuda T, Takada N, Osugi H, Higashino M, Kinoshita H . Prognostic significance of the MIB-1 proliferation index for patients with squamous cell carcinoma of the esophagus. Cancer. 1995; 76(3):358-66. DOI: 10.1002/1097-0142(19950801)76:3<358::aid-cncr2820760303>3.0.co;2-c. View

Lam K, Law S, So M, Fok M, Ma L, Wong J . Prognostic implication of proliferative markers MIB-1 and PC10 in esophageal squamous cell carcinoma. Cancer. 1996; 77(1):7-13. DOI: 10.1002/(SICI)1097-0142(19960101)77:1<7::AID-CNCR3>3.0.CO;2-N. View

Bourhis J, Dendale R, Hill C, Bosq J, Janot F, Attal P . Potential doubling time and clinical outcome in head and neck squamous cell carcinoma treated with 70 GY in 7 weeks. Int J Radiat Oncol Biol Phys. 1996; 35(3):471-6. DOI: 10.1016/s0360-3016(96)80008-3. View

10.

Bolger B, Symonds R, Stanton P, Maclean A, Burnett R, Kelly P . Prediction of radiotherapy response of cervical carcinoma through measurement of proliferation rate. Br J Cancer. 1996; 74(8):1223-6. PMC: 2075936. DOI: 10.1038/bjc.1996.520. View

11.

Kinugasa S, Tachibana M, Hishikawa Y, Abe S, Yoshimura H, Monden N . Prognostic significance of proliferating cell nuclear antigen (PCNA) in squamous cell carcinoma of the esophagus. Jpn J Clin Oncol. 1996; 26(6):405-10. DOI: 10.1093/oxfordjournals.jjco.a023256. View

12.

Nakano T, Oka K, Ishikawa A, Morita S . Correlation of cervical carcinoma c-erb B-2 oncogene with cell proliferation parameters in patients treated with radiation therapy for cervical carcinoma. Cancer. 1997; 79(3):513-20. View

13.

Fortin A, Morency R, Roy J, Monteil R, Tetu B . Markers of radioresistance in squamous cell carcinomas of the head and neck: a clinicopathologic and immunohistochemical study. J Clin Oncol. 1997; 15(3):1030-8. DOI: 10.1200/JCO.1997.15.3.1030. View

14.

Zackrisson B, Gustafsson H, Stenling R, Flygare P, Wilson G . Predictive value of potential doubling time in head and neck cancer patients treated by conventional radiotherapy. Int J Radiat Oncol Biol Phys. 1997; 38(4):677-83. DOI: 10.1016/s0360-3016(97)00066-7. View

15.

Trott K . Cell repopulation and overall treatment time. Int J Radiat Oncol Biol Phys. 1990; 19(4):1071-5. DOI: 10.1016/0360-3016(90)90036-j. View

16.

BEGG A, Hofland I, Moonen L, Bartelink H, Schraub S, Bontemps P . The predictive value of cell kinetic measurements in a European trial of accelerated fractionation in advanced head and neck tumors: an interim report. Int J Radiat Oncol Biol Phys. 1990; 19(6):1449-53. DOI: 10.1016/0360-3016(90)90357-p. View

17.

Masunaga S, Ono K, Abe M . A method for the selective measurement of the radiosensitivity of quiescent cells in solid tumors--combination of immunofluorescence staining to BrdU and micronucleus assay. Radiat Res. 1991; 125(3):243-7. View

18.

Greenwell A, Foley J, Maronpot R . An enhancement method for immunohistochemical staining of proliferating cell nuclear antigen in archival rodent tissues. Cancer Lett. 1991; 59(3):251-6. DOI: 10.1016/0304-3835(91)90149-c. View

19.

Yu C, Woods A, Levison D . The assessment of cellular proliferation by immunohistochemistry: a review of currently available methods and their applications. Histochem J. 1992; 24(3):121-31. DOI: 10.1007/BF01047461. View

20.

Wolf H, Dittrich K . Detection of proliferating cell nuclear antigen in diagnostic histopathology. J Histochem Cytochem. 1992; 40(9):1269-73. DOI: 10.1177/40.9.1354677. View